How should the arterial blood gas results (pH 7.14, PaCO₂ ≈ 52 mm Hg, PaO₂ ≈ 96 mm Hg, HCO₃⁻ ≈ 17 mmol/L) be interpreted and managed?

ABG Interpretation and Management

This patient has severe mixed respiratory and metabolic acidosis (pH 7.14) with hypercapnia (pCO₂ 51.9 mmHg) and requires immediate initiation of non-invasive ventilation (NIV) along with controlled oxygen therapy targeting SpO₂ 88-92%, while simultaneously investigating and treating the underlying metabolic acidosis.

ABG Analysis

This arterial blood gas shows:

• Severe acidemia: pH 7.14 (normal 7.35-7.45)
• Respiratory acidosis: pCO₂ 51.9 mmHg (normal 35-45 mmHg)
• Metabolic acidosis: HCO₃⁻ 17.3 mmol/L (normal 22-26 mmol/L)
• Adequate oxygenation: pO₂ 95.7 mmHg (acceptable)

The low pH with both elevated CO₂ and low bicarbonate indicates a mixed respiratory and metabolic acidosis—both systems are contributing to the severe acidemia.

Immediate Management Algorithm

Step 1: Oxygen Therapy (First Priority)

• Target SpO₂ 88-92% using controlled oxygen delivery 1
• Use 24-28% Venturi mask or nasal cannulae at 1-2 L/min initially 1
• Critical warning: Avoid excessive oxygen (PaO₂ >10.0 kPa/75 mmHg increases respiratory acidosis risk) 1
• Never abruptly stop oxygen—this causes life-threatening rebound hypoxemia 1

Step 2: Non-Invasive Ventilation (Urgent)

NIV should be started immediately because 2:

• pH <7.35 (this patient has pH 7.14—critically low)
• PaCO₂ ≥6.5 kPa (51.9 mmHg = 6.9 kPa, exceeding threshold)
• This represents Grade A evidence for NIV initiation

The 2016 BTS/ICS guideline specifically states NIV should begin when pH <7.35 with PaCO₂ ≥6.5 kPa persists after optimal medical therapy 2. Given the severity (pH 7.14), do not wait the full hour—initiate NIV promptly while optimizing medical management.

Step 3: Address the Metabolic Component

The low bicarbonate (17.3 mmol/L) indicates significant metabolic acidosis requiring investigation:

• Calculate anion gap to determine if high anion gap vs. normal anion gap acidosis
• Check lactate, ketones, renal function, toxin screen
• Review medications and clinical context
• Treat underlying cause (sepsis, diabetic ketoacidosis, renal failure, etc.)

Important caveat: The BTS guidelines note that NIV use has evolved beyond COPD, and mixed metabolic-respiratory acidosis requires careful assessment 2. However, with this degree of hypercapnia (pCO₂ 51.9) and severe acidemia, the respiratory component clearly warrants NIV.

Step 4: Monitoring

• Repeat ABG in 30-60 minutes after initiating therapy 1
• Monitor respiratory rate (if >23 breaths/min, supports NIV indication) 2
• Track vital signs and mental status
• Assess for NIV failure requiring intubation

Critical Pitfalls to Avoid

1. Do not give high-flow oxygen without blood gas monitoring—this worsens hypercapnic respiratory failure 1
2. Do not delay NIV waiting for metabolic correction—the respiratory acidosis alone (pH 7.14, pCO₂ 51.9) mandates ventilatory support 2
3. Do not assume pure COPD exacerbation—the low bicarbonate indicates a mixed picture requiring broader investigation 2
4. Do not abruptly stop oxygen if adjusting therapy—titrate down gradually to prevent rebound hypoxemia 1

Clinical Context Matters

While the guidelines were written primarily for COPD exacerbations 2, the principles apply to any hypercapnic respiratory failure. The severely low pH (7.14) represents life-threatening acidemia regardless of etiology. The respiratory component requires immediate NIV, while you simultaneously work up and treat the metabolic acidosis.

The adequate oxygenation (pO₂ 95.7) suggests the patient may already be receiving supplemental oxygen—ensure this is controlled at 88-92% saturation to avoid worsening CO₂ retention 1.